Bristol Myers Squibb BMY
NYSE BMY
$62.58 +1.46 (+2.38%)
As of: Oct 22, 2026 · 10:55 AM EDT

Bristol Myers Squibb (BMY) Land & Improvements (2025 - 2026)

Updated

Bristol Myers Squibb's Land & Improvements was $157 million in Q2 2026, unchanged from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Land & Improvements (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn -
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn -
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn -
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn -
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn -
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn -
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn -
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn -
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -
10 Bristol Myers Squibb 127.73 Bn 79.00 Bn 9.25 Bn 157.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 157.00 Mn
Mar 31, 2026 157.00 Mn
Dec 31, 2025 157.00 Mn
API Access

Bristol Myers Squibb Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=BMY&period=max&api_key=YOUR_API_KEY